SipNose Overview
SipNose focuses on nose-to-brain medical applications and is developing a nasal delivery platform for local, systemic, and central nervous system indications. The company’s intranasal drug-delivery platform uses a mechanism designed to improve efficacy, patient compliance, and safety. SipNose’s noninvasive devices are designed to ensure accurate dose delivery via the nasal cavity and incorporate a simple, efficient mechanism to allow localization of the aerosolized drug in the olfactory epithelium, resulting in better absorption into the olfactory bulb and brain. The company’s technology enables drug molecules of vast chemical and pharmaceutical characteristics to reach the brain faster and more efficiently with higher safety and improved patient experience.
Latest News
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | Acquired |
| Rounds | 0 |
| Investors | 0 |
Team Members
2
Employees: 1-10
Web & Social Links
| Website | sipnose.com |
Locations
13 Hayetzira St., Yokne'am Illit, Israel
Photos & Videos
2 item(s)
SipNose Business
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug DeliveryMedical DevicesMedical Treatment & TherapeuticsTarget Customer
Healthcare & Life SciencesLife SciencesPharmaceuticalsBiotechnologyHealthcareProvidersPatientsConsumersDemographics & FamilyChildrenSeniorsCore Technology
—Tags (21)
neurologypharmaceuticalspharma-companiesnon-invasivemedical-devicesdrug-deliverypatent-pendingmedical-productsalzheimers-diseasemedical-cannabishealthcare-providerschildrenepilepsydegenerative-diseaseshospitalsmedical-technologiestreatmentsseniorshome-caretherapeutic-devicesclinicsGeographic Markets
GlobalSipNose Financials
Public Offering / Exit
SipNose Lifecycle
All Events
SipNose News
2 articlesEmployee Info
| Employees (range) | 1-10 |
| Exact count | 2 |
| Team members | 2 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 16 classification IDs that could be used for matching.
SipNose Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 97/100 |
| Missing | funding rounds, markets |
| BI Verification | Jenny Sotnik-Talisman |
| Registrar ID | 514310739 |
| Crunchbase | sipnose |
| Phone | +97248200881 |
| Creator | Yanina Wainscheinker |
| Creator email | yanina.wain@gmail.com |
| Last updater | Yanina Wainscheinker |
| Updater email | yanina.wainscheinker@sncentral.org |
| Last update | 2022-11-17T00:00:00.000Z |
| Created | 2015-07-24T00:00:00.000Z |
| Status detail | Acquired by Aptar Pharma on Oct, 2024 |